Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study

  • Roy Vitkon
  • , Dan Netanely
  • , Shai Levi
  • , Tomer Ziv-Baran
  • , Ronit Ben-Yzak
  • , Ben Zion Katz
  • , Noam Benyamini
  • , Svetlana Trestman
  • , Moshe Mittelman
  • , Yael Cohen
  • , Irit Avivi

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology